- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 7/08 - Peptides linéaires ne contenant que des liaisons peptidiques normales ayant de 12 à 20 amino-acides
Détention brevets de la classe C07K 7/08
Brevets de cette classe: 7041
Historique des publications depuis 10 ans
455
|
445
|
458
|
495
|
498
|
456
|
462
|
416
|
413
|
271
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
Proprétaire |
Total
|
Cette classe
|
---|---|---|
Immatics Biotechnologies GmbH | 1153 |
245 |
The Regents of the University of California | 20059 |
108 |
Bicyclerd Limited | 146 |
77 |
Centre National de La Recherche Scientifique | 10516 |
71 |
Protagonist Therapeutics, Inc. | 137 |
57 |
Caregen Co., Ltd. | 312 |
53 |
Bicycletx Limited | 186 |
51 |
Bristol-myers Squibb Company | 4867 |
47 |
Toagosei Co., Ltd. | 974 |
44 |
GemVax & Kael Co., Ltd. | 93 |
41 |
Agency for Science, Technology and Research | 3639 |
35 |
The University of British Columbia | 1508 |
35 |
Seoul National University R&db Foundation | 3666 |
35 |
Kagoshima University | 309 |
33 |
The Trustees of the University of Pennsylvania | 4337 |
31 |
Peptidream Inc. | 80 |
30 |
Bausch Health Ireland Limited | 795 |
30 |
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2869 |
29 |
The Johns Hopkins University | 5709 |
27 |
The Arizona Board of Regents on Behalf of the University of Arizona | 2179 |
26 |
Autres propriétaires | 5936 |